Breast cancer in the Pan-American region: Inequities in incidence and mortality rates according to the human development index
Barrios CH, Werutsky G, Martínez-Mesa J. San Antonio Breast Cancer Symposium 2013; Abstract P1-09-06 Full link: https://cancerres.aacrjournals.org/content/73/24_Supplement/P1-09-06
HPV vaccine programs in Latin America run the risk of repeating the problems associated with Papanicolaou (Pap) test programs, an efficient, life-saving tool that is unfortunately underutilized for cancer prevention, in low- and middle-income countries. There is a great need for vigilance in the ongoing implementation of the HPV vaccine in Latin America.
A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane
(LACOG 0801).Gomez H, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowsky H, Neron Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capo A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH.San Antonio Breast Cancer Symposium 2013; Abstract P4-12-26 Full link: https://cancerres.aacrjournals.org/content/73/24_Supplement/P4-12-26
Inequities in Pap smear screening for cervical cancer between Brazilian urban and rural populations.
Jeovany Martínez-Mesa, Gustavo Werutsky, Carlos Alberto Sampaio-Filho, Aknar Calabrich, Carlos H. BarriosJ Clin Oncol 31, 2013 (suppl; abstr e12510) Full link: https://meetinglibrary.asco.org/record/82753/abstract